N-acetyltransferase 2
| GO Term | Evidence Code | PMID |
|---|---|---|
| xenobiotic metabolic process |
| GO Term | Evidence Code | PMID |
|---|---|---|
| arylamine N-acetyltransferase activity | ||
| arylamine N-acetyltransferase activity | ||
| protein binding | ||
| N-hydroxyarylamine O-acetyltransferase activity |
| Gene Ontology |
|---|
| acetyltransferase activity |
| arylamine N-acetyltransferase activity |
| transferase activity |
| InterPro |
|---|
| Arylamine N-acetyltransferase |
| Papain-like cysteine peptidase superfamily |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:10283 | prostate cancer | |
| DOID:11054 | urinary bladder cancer | |
| DOID:1240 | leukemia | |
| DOID:1324 | lung cancer | |
| DOID:13241 | Behcet's disease | |
| DOID:14330 | Parkinson's disease | |
| DOID:1790 | malignant mesothelioma | |
| DOID:1793 | pancreatic cancer | |
| DOID:2671 | transitional cell carcinoma | |
| DOID:2841 | asthma |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025